The non-steroidal anti-in¯ammatory drug (NSAID) diclofenac is used as a perioperative analgesic in our neurosurgical unit for awake craniotomy and supratentorial tumour resections. Indomethacin, another NSAID, is known to signi®cantly decrease cerebral blood¯ow (CBF) and intracranial pressure without changing cerebral metabolic rate.
1 Animal studies using diclofenac show no change in CBF but this has not been studied in man. 2 Major changes in cerebral physiology with drugs such as indomethacin have signi®cant clinical implications in neuroanaesthesia and it is important that the cerebral effects of all pharmacological agents are known. The aim of our investigation was to determine the effect of diclofenac on CBF velocity (CBFV) in patients with supratentorial pathology.
Methods and results
After obtaining approval from the Hospital Ethics Committee and written, informed consent, nine patients undergoing elective supratentorial neurosurgery were recruited. Patients were excluded if they had asthma, renal impairment, peptic ulcer disease, bleeding diathesis or had ingested NSAIDs within 24 h. No patient had signs of raised intracranial pressure.
The study was performed in the anaesthetic room before induction of anaesthesia. Patients were not premedicated and were kept in the supine position throughout the study period, with the head resting on a pillow. I.V. and arterial cannulae were inserted under local anaesthesia. Monitors included ECG, continuous arterial pressure, arterial blood gas sampling and axillary temperature.
CBFV was monitored continuously on the ipsilateral side of the intracerebral pathology. The M1 segment of the middle cerebral artery was insonated through the temporal window using a 2 MHz transcranial Doppler (TCD) ultrasound probe (Pioneer EME TCD VER 2.10, Eden Medical Electronics, U È berlingen, Germany). The TCD probe was ®xed in position to maintain a constant angle of insonation throughout the study. Con®rmation of the middle cerebral artery was achieved by increasing sonation depth to visualization of the bidirectional¯ow pattern typical of the bifurcation of the internal carotid artery to the middle cerebral and anterior cerebral arteries. Insonation depth was then decreased to the point of maximum signal intensity (45±55 mm depth). The TCD frequency spectra, converted into¯ow velocity (cm s ±1 ), were calculated automatically by the TCD over 4±5 consecutive cardiac cycles.
Measurements of baseline mean and systolic CBFV were recorded, along with mean arterial pressure, heart rate, temperature, and arterial oxygen and carbon dioxide pressures. Diclofenac, 75 mg in 50 ml normal saline, was then infused over 15 min. The i.v. route was chosen to avoid ®rst-pass metabolism and provide a reliable peak plasma concentration. All measurements were repeated at the end of the infusion (time 15 min) and after a further 25 min (time 40 min), to coincide with the time of peak plasma concentrations.
Anaesthesia was then commenced and surgery continued as normal.
Data are expressed as mean (SD). Data from previous studies indicate that the mean value for CBFV is 65.55 (4.2) cm s ±1 under normal physiological conditions. 3±6 A change of >2 SD was considered signi®cant and with a power of 0.8, a=0.05 and b=0.2, we calculated that eight subjects would be required.
Analysis of variance (ANOVA) for repeated measurements was used to compare the values. The changes from baseline to time 15 min and baseline to time 40 min following diclofenac administration were estimated separately. A value of P<0.05 was considered statistically signi®cant.
Nine patients were recruited. The mean age was 49.6 (range 25±72) and the mean weight was 73.2 (13.8) kg. The effects of diclofenac on physiological variables are shown in Table 1 . There was no statistical difference between measurements of CBFV at 15 and 40 min compared with baseline. No statistical differences were found between the physiological variables of mean arterial pressure, heart rate, temperature, and arterial oxygen and carbon dioxide pressures. Results of the tissue analysis in the nine volunteers revealed ®ve gliomas, two astrocytomas, one lymphoma and one in¯ammatory tissue.
Comments
We ®nd that diclofenac provides useful perioperative analgesia in a select group of neurosurgical patients but we were unsure of its effects on cerebral physiology. Animal studies have shown that diclofenac has no effect on cerebral haemodynamics but this had not been con®rmed in humans, or in this patient population. The results of this study demonstrate that diclofenac does not cause signi®cant changes in CBFV. We compared mean and systolic CBFV before and after the administration of diclofenac in patients with supratentorial pathology. Other physiological parameters that might have affected CBF remained constant. The patients were awake during the experiment and received no pharmacological agents other than diclofenac in normal saline 50 ml, thus avoiding potential alterations of CBF or intracerebral vessel diameter.
Indomethacin, another NSAID, is a potent cerebral vasoconstrictor. It decreases CBF by up to 40% without a change in cerebral metabolic rate, similar to the effects of hypocapnia. However, this effect appears to be unique among the NSAIDs. Its mechanism of cerebral vasoconstriction is still uncertain, but seems to result from mechanisms other than prostaglandin inhibition. 7 The role of NSAIDs in the management of cerebral injury has also been investigated. NSAIDs may improve collateral circulation in ischaemic brain and prevent cerebral vasospasm following subarachnoid haemorrhage. 8 9 Indomethacin has been used to control intracranial pressure and improve operating conditions in patients with cerebral tumours. 10 We chose to study patients with intracerebral pathology as this may alter CBF and its regulation, and for the practical reason that this re¯ects our clinical patient population likely to receive diclofenac. As our numbers are small, we may have overlooked a signi®cant response to diclofenac with a given tumour type, although no trend was seen.
Absolute CBF cannot be inferred from measurements of CBFV because the diameter of the insonated vessel segment is unknown. Despite this, the use of the TCD to measure CBFV has been shown to provide a good correlation between changes in¯ow velocity and cerebral blood¯ow as long as measurement conditions such as insonation angle and depth remain constant.
11
In conclusion, we have shown that there is no signi®cant change in CBFV after the administration of diclofenac in a small group of patients with supratentorial tumours. 
